CrossCart to test ACL (anterior cruciate ligaments) xenograft device
This article was originally published in Clinica
A technology that removes the carbohydrates from xenografts that are responsible for rejection could allow surgeons to use ligaments from pigs to repair knee injuries in humans.
You may also be interested in...
With its US/Mexico Phase III trial delayed due to manufacturing questions, Novavax has aligned its UK study with FDA guidance. It hopes for interim data from that study during Q1 2021.
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.